We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+32.27%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.08B
AUM Growth
+$1.74B
Cap. Flow
-$87.7M
Cap. Flow %
-0.97%
Top 10 Hldgs %
9.36%
Holding
1,266
New
118
Increased
373
Reduced
465
Closed
88

Top Buys

Rank Stock Value
1
SII
Sprott
SII
+$47.7M
2
HOMB icon
Home BancShares
HOMB
+$17.9M
3
WSO icon
Watsco Inc
WSO
+$17.4M
4
ROCK icon
Gibraltar Industries
ROCK
+$15.9M
5
SBNY
Signature Bank
SBNY
+$14.7M

Top Sells

Rank Stock Value
1
AL
Air Lease Corp
AL
+$19.4M
2
PLCE icon
Children's Place
PLCE
+$16.1M
3
FELE icon
Franklin Electric
FELE
+$15.9M
4
HEI icon
HEICO Corp
HEI
+$13.1M
5
Y
Alleghany Corp
Y
+$13.1M

Sector Composition

Rank Sector Weight
1 Industrials 24.1%
2 Technology 20.79%
3 Financials 14.06%
4 Consumer Discretionary 12.17%
5 Healthcare 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOO icon
651
Steven Madden
SHOO
$3.22B
$2.17M 0.02%
87,969
+718
+0.8% +$16.8K
STRL icon
652
Sterling Infrastructure
STRL
$16.5B
$2.17M 0.02%
206,940
-279,600
-57% -$2.58M
CNMD icon
653
CONMED
CNMD
$1.33B
$2.16M 0.02%
30,000
PEN icon
654
Penumbra
PEN
$12.6B
$2.15M 0.02%
12,000
-5,000
-29% -$868K
WEYS icon
655
Weyco Group
WEYS
$374M
$2.12M 0.02%
97,992
AXSM icon
656
Axsome Therapeutics
AXSM
$12.1B
$2.12M 0.02%
25,700
-14,400
-36% -$1.11M
EMR icon
657
Emerson Electric
EMR
$85B
$2.11M 0.02%
34,000
-4,000
-11% -$227K
TRHC
658
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$2.1M 0.02%
38,400
VICR icon
659
Vicor
VICR
$8.76B
$2.09M 0.02%
29,000
NPKI
660
NPK International
NPKI
$1.09B
$2.08M 0.02%
933,228
-765,095
-45% -$1.3M
ALRM icon
661
Alarm.com
ALRM
$2.7B
$2.07M 0.02%
32,000
JYNT icon
662
The Joint Corp
JYNT
$123M
$2.07M 0.02%
135,700
-29,300
-18% -$384K
CLAR icon
663
Clarus
CLAR
$128M
$2.03M 0.02%
175,703
-1
-0% -$10
VALU icon
664
Value Line
VALU
$344M
$2.01M 0.02%
74,574
CEVA icon
665
CEVA Inc
CEVA
$883M
$1.98M 0.02%
53,000
+6,000
+13% +$192K
CALY
666
Callaway Golf Company
CALY
$3.28B
$1.98M 0.02%
113,000
-31,000
-22% -$431K
PI icon
667
Impinj
PI
$4.05B
$1.98M 0.02%
72,000
+8,000
+13% +$187K
AMBA icon
668
Ambarella
AMBA
$3.03B
$1.97M 0.02%
43,000
APYX icon
669
Apyx Medical
APYX
$163M
$1.96M 0.02%
353,900
-37,131
-9% -$154K
TBPH icon
670
Theravance Biopharma
TBPH
$875M
$1.96M 0.02%
93,300
CSLT
671
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.95M 0.02%
2,349,034
+110,000
+5% +$81.7K
BBCP icon
672
Concrete Pumping Holdings
BBCP
$513M
$1.92M 0.02%
552,415
+366,381
+197% +$1.12M
EIC
673
Eagle Point Income Co
EIC
$231M
$1.92M 0.02%
148,128
FRST icon
674
Primis Financial Corp
FRST
$398M
$1.9M 0.02%
196,243
-90,255
-32% -$868K
CEMI
675
DELISTED
Chembio diagnostics, Inc.
CEMI
$1.9M 0.02%
584,342
-590,974
-50% -$5.61M

Similar funds

Royce & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Royce & Associates held 1,266 positions worth $9.08B, up 24% from $7.34B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates's Q2 2020 filing shows 118 new, 373 increased, 465 reduced and 88 closed positions. Its largest new stake was Sprott: 1,375,858 shares worth $49.4M. The largest sale was Air Lease Corp, an estimated $19.4M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2020 buy was Sprott: 1,375,858 shares worth $49.4M.
  • Royce & Associates added most to Home BancShares in Q2 2020, an estimated $17.9M increase.
  • Royce & Associates's biggest Q2 2020 reduction was Air Lease Corp, cutting an estimated $19.4M.
  • Royce & Associates fully exited KEMET Corporation in Q2 2020, selling an estimated $8.11M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $9.08B portfolio in Q2 2020.
  • Royce & Associates opened 118 new positions and closed 88 in Q2 2020.
  • Royce & Associates's portfolio value rose 24% quarter-over-quarter to $9.08B.

Based on Royce & Associates's 13F filing for Q2 2020, filed 7 Aug 2020.